0
Tonix Pharmaceuticals Holding Corp. Banner Image

Tonix Pharmaceuticals Holding Corp. has reached its limit for free report views

Work for Tonix Pharmaceuticals Holding Corp.? Upgrade Your Profile and unlock all your annual reports.

Tonix Pharmaceuticals Holding Corp.

  • Ticker TNXP
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Tonix Pharmaceuticals Holding Corp. Logo Image
  • 11-50 Employees
  • Based in New York City, New York
Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is primarily composed of central nervous system (CNS) and immunology product candidates. The immunology portfolio includes vaccines to prevent infectious diseases and biologicsMore to address immunosuppression, cancer and autoimmune diseases. The CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Tonix’s lead vaccine candidate, TNX-1800*, is a live replicating vaccine based on the horsepox viral vector platform to protect against COVID-19, primarily by eliciting a T cell response.
Tonix Pharmaceuticals Holding Corp.

Most Recent Annual Report

Tonix Pharmaceuticals Holding Corp. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Tonix Pharmaceuticals Holding Corp. has reached its limit for free report views.

Older/Archived Annual Reports